AU6532498A - Inhibition of ige-mediated allergies by a human ige-derived oligopeptide - Google Patents

Inhibition of ige-mediated allergies by a human ige-derived oligopeptide

Info

Publication number
AU6532498A
AU6532498A AU65324/98A AU6532498A AU6532498A AU 6532498 A AU6532498 A AU 6532498A AU 65324/98 A AU65324/98 A AU 65324/98A AU 6532498 A AU6532498 A AU 6532498A AU 6532498 A AU6532498 A AU 6532498A
Authority
AU
Australia
Prior art keywords
ige
inhibition
mediated allergies
derived oligopeptide
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65324/98A
Inventor
A. Helm Birgit
Eduardo A Padlan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU6532498A publication Critical patent/AU6532498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65324/98A 1996-12-06 1997-12-05 Inhibition of ige-mediated allergies by a human ige-derived oligopeptide Abandoned AU6532498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3199196P 1996-12-06 1996-12-06
US60031991 1996-12-06
PCT/US1997/022348 WO1998024808A2 (en) 1996-12-06 1997-12-05 INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE

Publications (1)

Publication Number Publication Date
AU6532498A true AU6532498A (en) 1998-06-29

Family

ID=21862518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65324/98A Abandoned AU6532498A (en) 1996-12-06 1997-12-05 Inhibition of ige-mediated allergies by a human ige-derived oligopeptide

Country Status (2)

Country Link
AU (1) AU6532498A (en)
WO (1) WO1998024808A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100498198B1 (en) 1996-03-01 2005-09-09 노파르티스 아게 Peptide Immunogen for Vaccination against and Treatment of Allergy
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
AU3281100A (en) * 1999-02-25 2000-09-14 Peptide Therapeutics Limited Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
CN1348466A (en) * 1999-02-25 2002-05-08 史密丝克莱恩比彻姆生物有限公司 Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses
EP2361635A3 (en) * 2000-08-30 2011-09-14 Pfizer Products Inc. Anti IgE vaccines
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
CN107469064A (en) * 2016-06-08 2017-12-15 广州艾玫格生物科技有限公司 Biological antiallergic compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6408586A (en) * 1985-10-03 1987-04-24 Biotechnology Research Partners Limited Novel lipoprotein-based drug-delivery systems
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
FR2715304B1 (en) * 1994-01-26 1996-04-26 Merieux Serums Vaccins Pasteur Anti-allergic vaccine.
US5614370A (en) * 1994-03-18 1997-03-25 Merck & Co., Inc. Assay to identify human C5a antagonists and agonists

Also Published As

Publication number Publication date
WO1998024808A2 (en) 1998-06-11
WO1998024808A3 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
AU7113594A (en) Site specific synthesis of conjugated peptides
AU2730195A (en) Walking aid
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AUPN419395A0 (en) Plant protector
AU8156598A (en) New human cathepsin
AUPO264096A0 (en) Value improvement of clays
AU6438094A (en) Coumarin derivative and use thereof
AU2217797A (en) Synthesis of indolylmaleimides
AU6532498A (en) Inhibition of ige-mediated allergies by a human ige-derived oligopeptide
AU5537996A (en) Hookworm vaccine
AU4157097A (en) Synthesis of bisindolylmalimides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3526295A (en) Detection of spread spectrum signals
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU1181897A (en) Medical use of proteases
AU5326698A (en) New therapeutic use of a thienylcyclohexylamine derivative
AU5126298A (en) Inhibition of crib-biting
AU6442096A (en) Protection of trees
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU5014496A (en) Diphenylmethyl-azetidinone compounds and elastase inhibitor
AU6171196A (en) Therapeutic uses of ta99
AU5825896A (en) Well inhibition
AU2766495A (en) Human criptin growth factor
AU4682896A (en) Trocar